ALLIANCEBERNSTEIN L.P. - XERIS BIOPHARMA HOLDINGS INC ownership

XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 104 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of XERIS BIOPHARMA HOLDINGS INC
ValueSharesWeighting
Q3 2023$149,581
-19.0%
80,420
+14.2%
0.00%
Q2 2023$184,579
+187.4%
70,450
+78.8%
0.00%
Q1 2023$64,222
+22.6%
39,4000.0%0.00%
Q4 2022$52,402
+37.9%
39,400
+63.5%
0.00%
Q3 2022$38,000
+81.0%
24,100
+74.6%
0.00%
Q2 2022$21,00013,8000.00%
Other shareholders
XERIS BIOPHARMA HOLDINGS INC shareholders Q3 2022
NameSharesValueWeighting ↓
CAXTON CORP 6,039,028$9,421,00017.72%
Stonepine Capital Management, LLC 12,928,168$20,168,0009.07%
SINECERA CAPITAL, LLC 253,101$395,0000.46%
NEA Management Company, LLC 3,246,785$5,065,0000.25%
DELTEC ASSET MANAGEMENT LLC 537,926$839,0000.21%
Kamunting Street Capital Management, L.P. 75,000$117,0000.19%
Alpine Global Management, LLC 400,000$624,0000.15%
ARMISTICE CAPITAL, LLC 2,504,431$3,907,0000.07%
Redmile Group, LLC 1,046,587$1,633,0000.06%
IHT Wealth Management, LLC 335,287$523,0000.04%
View complete list of XERIS BIOPHARMA HOLDINGS INC shareholders